Jupiter Topco LLC Makes New $84.35 Million Investment in Humana Inc. $HUM

Key Points

• Jupiter Topco LLC acquired 212,346 Humana shares worth approximately $84.35 million, giving it a 0.18% stake. Institutional investors collectively own 92.38% of Humana.
• Analyst sentiment is mixed but leans positive: Piper Sandler and Evercore upgraded the stock to “overweight” and “outperform,” respectively, while the consensus rating remains “Hold” with a $403.91 target price.
• Humana recently exceeded quarterly expectations, reporting $7.61 in EPS versus $7.27 expected and $40.89 billion in revenue. Revenue increased 26.2% year over year, while shares opened at $390.06.

Jupiter Topco LLC acquired a new stake in Humana Inc. (NYSE:HUM - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 212,346 shares of the insurance provider's stock, valued at approximately $84,347,000. Jupiter Topco LLC owned approximately 0.18% of Humana at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. J. Goldman & Co LP acquired a new stake in shares of Humana during the 2nd quarter worth $258,000. EFG International AG acquired a new position in Humana in the second quarter valued at about $56,000. Ancora Advisors LLC acquired a new position in Humana in the second quarter valued at about $97,000. Redwood Grove Capital LLC bought a new stake in Humana during the second quarter worth about $23,464,000. Finally, Primecap Management Co. CA acquired a new stake in Humana during the second quarter worth about $3,674,000. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HUM shares. TD Cowen raised their target price on shares of Humana from $350.00 to $370.00 and gave the company a "hold" rating in a report on Friday, July 31st. Piper Sandler raised shares of Humana from a "hold" rating to an "overweight" rating and set a $463.00 price target for the company in a report on Thursday, July 30th. Sanford C. Bernstein reiterated an "outperform" rating and set a $425.00 price target on shares of Humana in a research report on Wednesday, June 3rd. Evercore raised shares of Humana from an "in-line" rating to an "outperform" rating and set a $480.00 price objective on the stock in a research note on Wednesday, July 29th. Finally, Zacks Research downgraded shares of Humana from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 11th. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $403.91.

Humana Stock Up 0.1%

Shares of NYSE HUM opened at $390.06 on Thursday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market cap of $46.84 billion, a price-to-earnings ratio of 36.90, a PEG ratio of 2.22 and a beta of 0.72. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The stock has a 50-day moving average price of $384.44 and a two-hundred day moving average price of $286.38.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business's revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.27 earnings per share. As a group, analysts forecast that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Humana Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.